Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients
暂无分享,去创建一个
Christian Trautwein | Frank Tacke | F. Tacke | C. Trautwein | O. Gressner | A. Koch | Alexander Koch | Olav A Gressner | Edouard Sanson | E. Sanson
[1] F. Lönnqvist,et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. , 2006, Kidney international.
[2] T. Forst,et al. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. , 2003, Clinical laboratory.
[3] S. O’Rahilly,et al. Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. , 2001, Diabetes.
[4] F. Tacke,et al. Resistin Serum Levels Are Associated with Insulin Resistance, Disease Severity, Clinical Complications, and Prognosis in Patients with Chronic Liver Diseases , 2006, The American Journal of Gastroenterology.
[5] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. , 2009, Chest.
[6] T. Yoshikawa,et al. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[7] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.
[8] M. Lazar,et al. The hormone resistin links obesity to diabetes , 2001, Nature.
[9] Rolf Rossaint,et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. , 2008, The New England journal of medicine.
[10] Anand Rohatgi,et al. Resistin Is an Inflammatory Marker of Atherosclerosis in Humans , 2005, Circulation.
[11] Martin L. Lee,et al. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock , 2007, Critical care medicine.
[12] P. Murdock,et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. , 2003, Biochemical and biophysical research communications.
[13] D. Stejskal,et al. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. , 2003, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[14] D. Greaves,et al. Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. , 2009, The Journal of clinical investigation.
[15] Joanna D. Holbrook,et al. Resistin is expressed in human macrophages and directly regulated by PPARγ activators , 2003 .
[16] C. Mantzoros,et al. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. , 2004, Diabetes care.
[17] P. Sucharda,et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. , 2003, European journal of endocrinology.
[18] Serum resistin (FIZZ3) protein is increased in obese humans. , 2004, The Journal of clinical endocrinology and metabolism.
[19] Brian W Whitcomb,et al. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations* , 2005, Critical care medicine.
[20] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[21] I. Vanhorebeek,et al. Glucose metabolism and insulin resistance in sepsis. , 2008, Current pharmaceutical design.
[22] R. Gambino,et al. Relationships between human serum resistin, inflammatory markers and insulin resistance , 2005, International Journal of Obesity.
[23] Stephen A. Smith,et al. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. , 2003, The Journal of clinical endocrinology and metabolism.
[24] S. Kumar,et al. Serum resistin is associated with C-reactive protein and LDL- cholesterol in type 2 diabetes and coronary artery disease in a Saudi population , 2005, Cardiovascular diabetology.
[25] A. Kitabchi,et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. , 2002, The Journal of clinical endocrinology and metabolism.
[26] F. Tacke,et al. Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4. , 2007, Diabetes care.
[27] S. Kumar,et al. Resistin, central obesity, and type 2 diabetes , 2002, The Lancet.
[28] A. Aljada,et al. Inflammation: the link between insulin resistance, obesity and diabetes. , 2004, Trends in immunology.
[29] M. Lazar,et al. Mechanisms of obesity-associated insulin resistance: many choices on the menu. , 2007, Genes & development.
[30] J. Flier,et al. The adipocyte as an active participant in energy balance and metabolism. , 2007, Gastroenterology.
[31] E. Draper,et al. APACHE II: A severity of disease classification system , 1985, Critical care medicine.
[32] K. Park,et al. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. , 2004, The Journal of clinical endocrinology and metabolism.
[33] B. Bistrian,et al. Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.
[34] G. Van den Berghe,et al. Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.